logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Humanitas Research Hospital

+390282241
ufficio.stampa@humanitas.it
Source: Site record.
https://www.humanitas.it

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Humanitas is a highly specialized hospital, research center, and university teaching facility located in Rozzano, Milan.Within the hospital, which is accredited by the Italian National Health Service, specialized centers provide treatment for cancer, cardiovascular, neurological, and orthopedic diseases, as well as ophthalmology services and a Fertility Center.IRCCS Istituto Clinico Humanitas also has a highly specialized EAS Emergency Department. Recognized by the Italian Ministry of Health as a Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Humanitas is a global reference center for research into diseases related to the immune system, ranging from cancer to rheumatoid arthritis.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. Private hospital

Business Subcategory

Source: Human-provided. Private hospital
Source: Human-provided. Government hospital
Source: Human-provided. Specialized hospital
Source: Human-provided. University hospital
Source: Trial-derived.
408Total Trials
Source: Trial-derived.
104Recruiting Trials
Source: Trial-derived.
122Active Trials
Source: Trial-derived.
2Completed Trials
Source: Trial-derived.
434Unique Conditions
Source: Trial-derived.
253Unique Sponsors

Conditions

Source: Trial-derived. Ulcerative Colitis (20)Source: Trial-derived. Breast Cancer (15)Source: Trial-derived. Crohn's Disease (13)Source: Trial-derived. Crohn Disease (12)Source: Trial-derived. Colorectal Cancer (10)Source: Trial-derived. Atopic Dermatitis (9)Source: Trial-derived. Colitis, Ulcerative (7)Source: Trial-derived. Lung Cancer (7)

Sponsors

Source: Trial-derived. Istituto Clinico Humanitas (68)Source: Trial-derived. Hoffmann-La Roche (31)Source: Trial-derived. Janssen Research & Development, LLC (26)Source: Trial-derived. Eli Lilly and Company (19)Source: Trial-derived. AbbVie (17)Source: Trial-derived. Merck Sharp & Dohme LLC (12)Source: Trial-derived. Bayer (11)Source: Trial-derived. Bristol-Myers Squibb (11)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Electronic data capture
Source: AI-inferred. Telehealth study visits
Source: AI-inferred. Electronic source (eSource) system

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. 12-lead ECG
Source: AI-inferred. CT Scan
Source: AI-inferred. Vibration-controlled transient elastography (FibroScan)
Source: AI-inferred. MRI
Source: AI-inferred. MRI proton density fat fraction
Source: AI-inferred. X-Ray

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Pharmacokinetic bioanalysis
Source: AI-inferred. ELISA / immunoassay

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling
Source: AI-inferred. Sterile preparation (laminar-flow hood / BSC or cleanroom)

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Endoscopy / colonoscopy
Source: AI-inferred. Liver biopsy
Source: AI-inferred. Radiation therapy
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Electronic patient-reported outcome (ePRO) diary system
Source: AI-inferred. Left ventricular ejection fraction assessment
Source: AI-inferred. Automated office blood pressure (AOBP) measurement
Source: AI-inferred. Cystoscopy
Source: AI-inferred. EGFR mutation testing
Source: AI-inferred. Enhanced liver fibrosis testing
Source: AI-inferred. FLT3-ITD mutation and minimal residual disease testing
Source: AI-inferred. Interferon gene signature expression testing